Important Safety Information
This site is intended for U.S. healthcare professionals only. U.S. healthcare professionals only. Visit patient site

FreeStyle Libre System  //  Clinical Evidence

Proven to be accurate1 and to reduce time spent in hypoglycemia2,5

FreeStyle Libre reader and sensor

Clinically proven to be accurate,1 stable, and consistent over 10 days

  • Factory calibration delivers proven accuracy1 and eliminates patient variables
  • Wired enzyme technology3 ensures stable sensor performance
FreeStyle Libre sensor

FreeStyle Libre system has a MARD of 9.7% over 10 days1 without fingerstick calibration

MARD shows the average percent disagreement between the FreeStyle Libre system and YSI reference

Graph showing mean absolute relative difference throughout 10-day wear period

Consensus Error Grid shows FreeStyle Libre system delivers proven accuracy1

In a study, 100% of glucose results were in Zones A and B of the Consensus Error Grid4

  • The FreeStyle Libre sensor readings had a high degree of agreement with YSI reference4
  • 92.6% of results were in Zone A4
Consensus error grid illustrates degree of agreement between FreeStyle Libre sensor readings and YSI reference

Want a professional CGM system with the same sensor technology?

Want a sales rep to provide more information?

FreeStyle Libre system offers better glucose control for your patients with diabetes2,5

Clinical trial results in T1D and T2D patients vs self-monitored blood glucose (SMBG) testing2,5

  • Increased patient engagement led to more frequent glucose monitoring2,5
  • Clinically proven to reduce time spent in hypoglycemia2,5
Daily patterns graph showing patient's glucose trends

Clinical trials have shown that FreeStyle Libre system increases glucose monitoring frequency for better clinical outcomes2,5

Increased frequency of glucose monitoring with FreeStyle Libre system
Increased frequency of glucose monitoring with FreeStyle Libre system

An increased time in target range and reduced time in hypoglycemia was seen in patients using the FreeStyle Libre system4

Reduction of time in hypoglycemia with FreeStyle Libre system
Reduction of time in hypoglycemia with FreeStyle Libre system

With the FreeStyle Libre system, patients experienced a reduction in a range of hypoglycemia measures2

Reduction in hypoglycemia with FreeStyle Libre system

Want a sales rep to provide more information?

Reference: 1. FreeStyle Libre User’s Manual. 2. Bolinder, Jan, et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. The Lancet 388.10057 (2016): 2254-2263 3. Hoss et al. Feasibility of Factory Calibration for Subcutaneous Glucose Sensors in Subjects with Diabetes, Journal of Diabetes Science and Technology 2014, Vol. 8(1) 89–94 4. Data on file. Abbott Diabetes Care. 5. Haak, Thomas, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin- treated type 2 diabetes: a multicenter, open- label randomized controlled trial. Diabetes Therapy 8.1 (2017): 55-73

ADC-05530 Ver 2.0 11/17

You are about to leave for a 3rd party website

The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.

Do you wish to leave this site?

Thank you for submitting your details. We will contact you as soon as possible.